As of January 2023, the X-waiver is no longer required to prescribe buprenorphine for opioid use disorder. Any references to the X-waiver no longer apply. The educational content on this site that offers CME meets the MATE Act requirements of 8 hours of training required for DEA certification.
The Provider Support Initiative (PSI) monthly webinars occur on the 2nd and 4th Tuesdays of each month 12-1PM (PT).
The objective of this webinar series is to elevate evidence based clinical practices to prescribe buprenorphine for opioid use disorder and address management of complex patients with co-occurring disorders, co-morbidities, and/or co-occurring substance use. Content will address stimulants (methamphetamine and cocaine) and fentanyl and include an emphasis to improve care for vulnerable priority populations (including but not limited to youth, American Indian/Alaska Native populations, and persons experiencing homelessness. Continuing Medical Education and Continuing Education (CME/CE) offered at NO COST.
Presenter(s): Joseph Crottogini, MPH
*Continuing the Conversation session
Note: Registering here will allow you to attend any of our future sessions. You can cancel your registration at any time.
For more information, contact Cfrable@mednet.ucla.edu